Medicure (TSXV:MPH) EV-to-Revenue : 0.35 (As of Apr. 25, 2024)

View and export this data going back to 1999. Start your Free Trial

What is Medicure EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medicure's enterprise value is C$5.55 Mil. Medicure's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$15.70 Mil. Therefore, Medicure's EV-to-Revenue for today is 0.35.

The historical rank and industry rank for Medicure's EV-to-Revenue or its related term are showing as below:

TSXV:MPH' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.2 Med: 1.66 Max: 9.79
Current: 0.34

During the past 13 years, the highest EV-to-Revenue of Medicure was 9.79. The lowest was -0.20. And the median was 1.66.

TSXV:MPH's EV-to-Revenue is ranked better than
95.02% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs TSXV:MPH: 0.34

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), Medicure's stock price is C$1.09. Medicure's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$1.66. Therefore, Medicure's PS Ratio for today is 0.66.

Medicure EV-to-Revenue Historical Data

The historical data trend for Medicure's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure EV-to-Revenue Chart

Medicure Annual Data

Trend

May14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

1.77

0.94

0.32

0.28

0.40

Medicure Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.28	0.28	0.31	0.70	0.40

Competitive Comparison of Medicure's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicure's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medicure's EV-to-Revenue falls into.

Medicure EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medicure's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	5.551	/	15.701
	=	0.35

Medicure's current Enterprise Value is C$5.55 Mil.
Medicure's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$15.70 Mil.

Medicure (TSXV:MPH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medicure's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	1.09	/	1.662
	=	0.66

Medicure's share price for today is C$1.09.
Medicure's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.66.

Medicure EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medicure's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicure (TSXV:MPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

MCUJF:USA NGQ1:Germany

Address

2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.medicure.com

Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure (TSXV:MPH) Headlines

No Headlines